Robert Michel
Until Robert L. Michel came along and founded The Dark Intelligence Group (DIG) two decades ago, the clinical laboratory industry and the anatomic pathology profession lacked a trustworthy source for information about the management and operations of medical laboratories. From its inception in 1995, The Dark Report quickly became the “go to” source of industry intelligence, innovations in lab management, and strategic market analysis.
This excellence in reporting has earned recognition from his peers. For example, twice Michel and The Dark Report have won national awards for best investigative reporting by the Specialty Information Publishers Association. In 2005, the award was for Michel’s coverage about how the anatomic pathology condominium laboratories (pod labs) operated by urologists and gastroenterologists came to be, who operated them, and how these owners marketed the AP condo labs to other physician groups. In 2009, Michel’s award for best investigative reporting resulted from his published interviews with Quest Diagnostics Incorporated when the company admitted that, for a period of 18 months, it had been reported inaccurate Vitamin 25(OH) D results because of problems with its laboratory-developed test methodology. The Dark Report’s story was picked up by The New York Times and was in the national news cycle for several days.
In his role as Editor-in-Chief, Michel brought unique capabilities to DIG and The Dark Report. His management training and diverse business experience—along with his skills as a concise writer and analyst—proved to be a winning combination for readers of The Dark Report. For that reason, Michel’s story has many intriguing elements.
Immediately prior to founding DIG, he had served in several executive positions for Nichols Institute based in Portland, Oregon, and San Juan Capistrano, California. This was during the time that Nichols Institute was an independent public lab company with annual revenues of about $280 million (prior to its acquisition by MetPath, Inc., now Quest Diagnostics Incorporated). He traveled extensively to many of the clinical lab business units owned by Nichols Institute in different regions of the United States and played a role in formulating effective market strategies in response to the emergence of closed-panel HMOs, capitated pricing, and full-risk managed care contracts, among other successful management initiatives.
Prior to his service at Nichols Institute, Michel served at three different Fortune 100 companies. These were Procter & Gamble, Centex Corporation, and Financial Corp. of America. Each was an opportunity to master new management techniques and apply them in different industries. Between these positions, he gained experience as an entrepreneur, having founded a real estate development firm and a general contracting company in the Southeastern United States.
Robert Michel earned a Bachelor of Arts degree in Economics at the University of California, Los Angeles, where he played rugby, a sport he participated in for another 22 years. He is a native of California and grew up in Santa Ana.
Articles by Robert Michel
Advanced Health Targets Integrated Health Networks
“The question that every clinical laboratory must now ask is this: will my lab be a technology differentiator or a technology enabler?” Rob Alger, Advanced Health Technology CEO SUMMARY: Many hospital-based laboratories have a different missio…
Healtheon Already Choice Of Public Lab Companies
CEO SUMMARY: Probably no single individual has greater insight about the changes now occurring to web-based laboratory test ordering and results reporting than Healtheon Corporation’s Nancy Ham. As Vice President of Connectivity & Institutional Services, Nancy is responsible for Hea…
“November 1, 1999 Intelligence: Late Breaking Lab News”
Well-run hospital laboratory outreach programs continue to thrive. Last week THE DARK REPORT was in Chicago to visit Genesis Clinical Laboratory. Located in Berwyn, Illinois, Genesis is a for-profit subsidiary of McNeal Hospital. During the last two years, Genesis Pr…
California’s Physicians Face Financial Meltdown
CEO SUMMARY: It’s a what-if scenario that may come true. Healthcare providers in the Golden State are going broke at an astounding rate. Physicians seem to be the hardest hit, but signs indicate that hospitals are also heading toward serious financial difficulties. In a nutshell, a deca…
Lab Venture in Houston To Include a New Partner
CEO SUMMARY: For months, lab industry rumors said the Memorial-Hermann merger had killed the Dynacare-Hermann Hospital laboratory joint venture, despite its sustained profitability. Now comes news that the Memorial Hermann Healthcare System and Dynacare will expand the laboratory joint ve…
Revamped Houston JV Validates Industry Trend
CEO SUMMARY: Change is notoriously slow in both the hospital and the clinical laboratory industry. The announcement of a revamped laboratory joint venture between Houston’s Memorial Hermann Healthcare System and Dynacare demonstrates that market pressures continue to encourage the ratio…
FDA Wants Abbott Labs To Toe Regulatory Line
CEO SUMMARY: In the short term, it’s Abbott Laboratories which must deal with increasingly aggressive FDA regulators. But the real story behind the story is that the FDA is stepping up regulatory oversight of the entire diagnostics industry. Abbott faces serious consequences if it canno…
Pap Smear Marketplace Shifting into High Gear
CEO SUMMARY: It took just four years to shake out the weakest competitors in the emerging field of automated cytology. Now only TriPath Imaging, Inc. and Cytyc Corporation remain in competition. Indications are that this will be a nasty battle. Pathologists and lab executives contemplatin…
UroCor, Unilab, AmeriPath, MedPartners, Epitope
UROCOR INKS PACT TO MATCH DIAGNOSTICS WITH THERAPEUTICS HERE’S A PIONEERING EFFORT to more closely link diagnostics and therapeutics into a single product package. UroCor, Inc. and Mallinckrodt, Inc. signed an agreement that allows Mallinckrodt to sell an…
“October 11, 1999 Intelligence: Late Breaking Lab News”
Here’s a hats-off to Ortho-Clinical Diagnostics (OCD). At a time when everything in the healthcare system seems to be taking things away from clinical laboratories, OCD has organized a worthwhile laboratory management best practices day for its most loyal customers. Started four ye…
CURRENT ISSUE
Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.